The burgeoning field ofinvestigations into novel anxiolytics is rapidly expanding, with untapped research chemicals showing favorable results in preclinical and clinical trials. These substances often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential benefits for individuals struggling with a